RNS Number : 2982S
NetScientific PLC
20 December 2016
 

 

 

("NetScientific" or the "Company" or the "Group")

 

Foad Dabiri Appointed CEO of Portfolio Company, Wanda

 

London, UK - 20 December 2016 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that Foad Dabiri has been appointed Chief Executive Officer of its portfolio company Wanda to take the company through its commercialisation phase.  Foad takes over with immediate effect from Steve Curd who has been Chief Executive Officer since September 2015 and will step down as Chief Executive Officer.

Foad Dabiri has been the Chief Technology Officer of Wanda since March 2014, where he has been instrumental in creating Wanda's unique cloud based platform for the management of chronic disease management and is uniquely placed to lead Wanda as it moves into commercialisation. Before joining Wanda, Foad was a Senior Software Engineer at Google Inc for three years. He has also worked as Principle Scientist at NetSeer Inc. Mr. Dabiri gained a PhD and M.S. in Computer Science at the University of California and, prior to that, was awarded a BS in Electrical Engineering from the Sharif University of Technology.

Commenting on the news, François R. Martelet, Chief Executive Officer of NetScientific and Chairman of Wanda, said: "Foad's unique understanding of the nexus between predictive analytics, data and patient need, make him the best person to lead Wanda at this critical juncture as it moves into its commercialisation phase. We are excited that he will be bringing his rare combination of skills to the company and look forward to working with him.

 

I would like to thank Steve Curd for his contribution to the Company during the early years and wish him all the best in the future."

 

Foad Dabiri, incoming Chief Executive Officer of Wanda, said: "We have seen first-hand the power of Wanda's predictive analytic capabilities in managing the health of people with chronic disease through our initial client base. Wanda's potential has become a reality and I am delighted to have been appointed to lead the company as it brings the platform to more and more patients and builds its commercial reach."

 

- Ends -

 

 

For more information, please contact:

 

NetScientific

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

 

Tel: +44 (0)20 3514 1800

 

Consilium Strategic Communications

Mary-Jane Elliott / Jessica Hodgson / Chris Welsh / Laura Thornton

 

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

 

 

About NetScientific Plc

 

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net

About Wanda

San Francisco-based Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning in place of conventional technologies and by enabling clinicians to make more informed care decisions. Wanda recognizes that remote monitoring and algorithms cannot save lives or reduce hospitalizations unless the individual and their caregivers are promptly informed and highly engaged. Through the collaboration of data science and applied medical research, Wanda has proven that its inline analytics predict preventable events much better than conventional methods. Wanda serves as a diligent companion, providing encouragement and intelligent visual guidance that simplifies and improves lives, while simultaneously helping organizations reduce their care delivery costs. Wanda is a NetScientific portfolio company. More information about Wanda can be found at www.yourwanda.com.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFESSSSFMSESE